Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1518 of 5804
-
Brain tumor radiation showdown: one shot or several?
Disease control Recruiting nowThis phase II trial compares the effect of single fraction stereotactic radiosurgery to fractionated stereotactic radiosurgery for the treatment of patients with cancer that has spread to the brain (metastatic brain disease). Stereotactic radiosurgery (SRS) is a form of radiation…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Hope for fabry pain: new drug trial targets nerve and belly discomfort
Symptom relief OngoingThis is a 12-month, parallel treatment, Phase 3, double-blind, randomized, placebo-controlled study to evaluate the effect of venglustat on neuropathic and abdominal pain symptoms of Fabry disease in participants ≥16 years of age with Fabry disease who are treatment-naïve or untr…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Robot suit helps stroke patients walk again sooner?
Symptom relief CompletedThe Ekso (Ekso Bionics) is a wearable exoskeleton that provides robotic support and walking assistance for patients with lower extremity paralysis. Research suggests that exoskeleton-assisted gait training is as effective as conventional gait training at improving walking outcome…
Sponsor: Sunnyview Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Real-world study shows lanadelumab keeps HAE attacks at bay for many patients
Disease control CompletedThe main aim of this study is to learn about how many persons with HAE type I or type II are attack-free when treated with lanadelumab in real life, how many attacks occur and how many of these attacks need rescue treatment and about the nature of HAE attacks. Participants will …
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could your own immune cells stop colon cancer returning?
Disease control Recruiting nowThis is a Phase I, open-label study to explore the safety profile and to find the maximum tolerated dose (MTD) or maximum feasible dose (MFD) of Magicell-NK in subjects diagnosed with stage I or stage IIa colon cancer post resection from a single site in Taiwan. During this stud…
Phase: PHASE1 • Sponsor: Medigen Biotechnology Corporation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Exercise and diet combo shows promise for diabetes control
Disease control OngoingThe aim of this randomized controlled trial is to investigate the effects of different aerobic modalities; moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT), and a nutritional intervention (D) on appetite regulation, appetite-related hormon…
Phase: NA • Sponsor: University of Cadiz • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Tiny cuts may speed healing of diabetic foot ulcers
Symptom relief CompletedThis randomized clinical trial will examine the effect of inforatio technique on healing of diabetic foot ulcers (DFUs). Inforatio technique is a novel procedure developed by the research group. The definition of inforatio technique is application of small cuts in wound beds wit…
Phase: NA • Sponsor: Zealand University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could one HPV shot be enough for kids with HIV? new study investigates
⭐️ VACCINE ⭐️ CompletedThis phase IV trial compares 3 different dosing schedules to find the optimal number of doses for HPV vaccination in children and adolescents living with HIV. Comparing 3 different dosing schedules may help researchers determine whether a single dose of HPV vaccine could be effec…
Phase: PHASE4 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 04, 2026 00:00 UTC
-
Magic mushroom therapy tested for End-of-Life distress
Symptom relief CompletedThe overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin
Phase: PHASE2 • Sponsor: Yvan Beaussant, MD, MSci • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
CBD shows promise in cutting opioid use and pain
Symptom relief CompletedThis is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to reduce opioid use, anxiety, and pain and improve sleep and cognitive function. If eligible for the study, subjec…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Experimental gene therapy targets common cancer protein
Disease control TerminatedBackground: Researchers have found a new way to treat cancer using T cell therapy. The therapy used in this study is T Cell Receptor (TCR) Gene Therapy Targeting Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1), a cancer germline antigen that is expressed by certain cancers. This the…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can exercise and diet beat muscle loss in seniors? new study says maybe.
Disease control CompletedThis study aims to demonstrate the effect of combined exercise-nutrition intervention in old adults with sarcopenia. This study will be conducted with prospectively randomized controlled trial comparing outcome of combined exercise-nutrition intervention with conventional medical…
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:55 UTC
-
New hope for rare autoimmune disease: baricitinib trial underway
Disease control OngoingSystemic Sclerosis (Ssc) is a rare, systemic autoimmune disease characterized by skin fibrosis and vasculopathy. In addition to the skin, it is a heterogeneous disease that affects multiple organs, including the musculoskeletal, cardiac, pulmonary, and gastrointestinal systems. P…
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Robot-Assisted breast surgery trial aims for better outcomes and sensation
Disease control Recruiting nowThis is a single arm, single-center, prospective clinical trial designed to track the peri, post-operative and oncologic outcomes when utilizing the da-Vinci single port (SP) robotic platform to perform robotic nipple sparing mastectomy (rNSM) and immediate breast reconstruction …
Phase: NA • Sponsor: Deborah Farr, MD • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New pill could curb binge eating episodes
Disease control CompletedThis pilot study is to assess the efficacy and safety of BP1.4979 15 mg BID in female patients with moderate to severe binge eating disorder (BED), as defined according to DSM-5 guidelines.
Phase: PHASE2 • Sponsor: Bioprojet • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common arthritis drug hold off a rare blood cancer?
Disease control OngoingThis phase II trial studies the effects of leflunomide in treating African-American and European-American patients with high-risk smoldering multiple myeloma. Leflunomide is used to decrease the body's immune response and may delay the symptoms of multiple myeloma in patients of …
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hope for Hard-to-Treat leukemia: Two-Drug combo enters human trials
Disease control Recruiting nowThis study will assess the safety, tolerability, pharmaokinetics, and preliminary efficacy of mosunetuzumab (Lunsumio) monotherapy in participants with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This study will also allow …
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo KarXT tested for Long-Term safety in schizophrenia
Disease control Recruiting nowThis is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with schizophrenia with an inadequate response to their current antipsychotic treatment who previously completed…
Phase: PHASE3 • Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New shot may curb heavy drinking in reward-driven people
Disease control Recruiting nowThis study is a phase IV, two-arm, randomized, double-blind, placebo-controlled study to assess whether individuals identified as primarily reward drinkers are significantly more likely to reduce heavy drinking if they receive XR-NTX than a matching placebo injection. Study subj…
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental drug targets rare pancreatic cancer in small trial
Disease control CompletedBackground: Pancreatic cancer is one of the most lethal types of cancer. American Society for Clinical Pathology (ASCP) is a highly aggressive type of pancreatic cancer. It is very rare. Researchers want to see if a drug called Minnelide can be used to treat ASCP. Objective: T…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC